Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: Subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes

NeuroImage

Volumn 12, Issue 6, 2000, Pages 747-756

  Valenzuela, M J ^a,b   Sachdev, P S ^a,b   Wen, W ^b   Shnier, R ^c   Brodaty, H ^a,b   Gillies, D ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; AGED; AGING; ARTICLE; COGNITION; FEMALE; FRONTAL CORTEX; GRAY MATTER; HUMAN; MALE; NEUROCHEMISTRY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

EID: 0033658774     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2000.0629     Document Type: Article

References (75)

1. Parrallel organisation of functionally segregated circuits linking basal ganglia and cortex
2. Adult cerebrovascular disease: Role in modified rapid fluid-attenuation inversion-recovery sequences
3. Temporal lobe pHi and IQ: No consistent correlation
4. Intelligence and brain structure in normal individuals
5. The anatomy of melancholia: Does frontal-subcortical pathophysiology underpin its psychomotor and cognitive manifestation?
6. Lifespan psychology: Theory and application to intellectual functioning
7. 1H MRS studies in vivo
8. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
9. Contribution of mitochondrial alterations to brain aging
10. Brain size, IQ, and Aging
11. Metabolism of the aging brain
12. Changes in cerebral glucose metabolism with normal aging
13. MRI of entorhinal cortex in mild Alzheimer's disease
14. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: A threshold effect
15. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study
16. Reproducibility of H-1-MRS in vivo
17. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly
18. In vivo proton magnetic resonance spectroscopy of the normal aging human brain
19. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease
20. Short-term mental activation accelerates the age-related decline of high-energy phosphates in rat cerebral cortex
21. Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration
22. Correlates of executive function in multiple sclerosis: The use of magnetic resonance spectroscopy as an index of focal pathology
23. Longitudinal cognitive, electroencephalographic and morphological brain changes in ageing and Alzheimer's disease
24. Brain atrophy in normal ageing and Alzheimer's disease: Volumetric discrimination and clinical correlations
25. Magnetic resonance spectroscopy in psychiatry: Basic principles and applications
26. Cognitive neuroscience of human memory
27. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia
28. Amidohydrolases of brain: Enzymatic hydrolysis of N-acetyl-L-aspartate and other N-acyl-L-amino acids
29. Histochemically distinct compartments in the striatum of human being, monkey and cat demonstrated by the acetlycholinesterase staining method
30. Metabolic and destructive brain disorders in children: Findings with localized proton MR spectroscopy
31. Periventricular white matter changes and dementia. Clinical, neuropsychological, radiological, and pathological correlations
32. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS
33. Cerebral glucose/energy metabolism: Valid techniques in humans and animals
34. Clinical significance of MRI white matter lesions in the elderly
35. Neuropsychological tests' norms above age 55: COWAT, MAE Token, WRAT-R Reading, AMNART, STROOP, TMT, and JLO
36. Mayo's older Americans normative studies: WAIS-R norms for ages 57-97
37. Mayo's older Americans normative studies: WMS-R norms for ages 56-94
38. Biochemical markers of intelligence: A proton MR spectroscopy study of normal human brain
39. Biochemical markers of cognition: A proton MR spectroscopy study of normal human brain
40. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy
41. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia
42. What counts in brain aging? Design-based stereological analysis of cell number
43. Computed tomography-but not magnetic resonance imaging-identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's Disease
44. 1H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and choline
45. Preservation of prefrontal cortical volume in behaviorally characterized macaque monkeys
46. Cognitive declines correlate with decreased: Cortical volume and perfusion in dementia of the Alzheimer type
47. Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions
48. Pathogenesis of leukoaraiosis: A review
49. Proton MR spectroscopy of the brain in infants
50. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping
51. Brain biochemistry in Williams syndrome: Evidence for a role of the cerebellum in cognition?
52. Is pH a biochemical marker of IQ?
53. Neuroanatomical correlates of age-sensitive and age-invariant cognitive abilities: An In vivo MRI investigation
54. In vivo magnetic resonance spectroscopy of human brain: The biophysical basis of dementia
55. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders
56. Applications of magnetic resonance spectroscopy to psychiatry
57. The cognitive neuroscience of memory: Perspectives from neuroimaging research
58. Histopathological correlates of white matter changes on MRI in Alzheimer's disease and normal aging
59. Neuropsychologic correlates of white matter hyperintensities: A study of 150 normal volunteers
60. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy
61. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
62. Storage and executive processes in the frontal lobes
63. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis)
64. N-Acetylaspartate in neuropsychiatric disorders
65. A method to improve interrater reliability of visual inspection of brain MRI scans in dementia
66. High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: A 31 phosphorous magnetic resonance spectroscopic and neuropsychological investigation
67. In vivo brain size, head perimeter and intelligence in a sample of healthy adult females
68. In vivo brain size and intelligence
69. White matter hyperintensities on MRI in the neurologically nondiseased elderly: Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home
70. White matter changes in healthy elderly persons correlate with attention and speed of mental processing